![Highlights from the 6th Annual NCODA Oncology Institute](https://oncodaily.com/pub/uploads/2024/08/IMG_6643-1.jpeg)
Highlights from the 6th Annual NCODA Oncology Institute
The NCODA Oncology Institute is an influential gathering for oncology professionals, designed to foster the development of comprehensive and cutting-edge practices in cancer care. Organised by the National Community Oncology Dispensing Association (NCODA), this institute is a leading platform for advancing the role of medically integrated dispensing and enhancing patient-centered oncology services.
The institute features a comprehensive curriculum tailored to the diverse needs of oncology care teams. Educational sessions are led by prominent experts in the field and focus on the latest advancements in oncology treatment protocols, medication management, and best practices in medically integrated dispensing. The goal is to ensure that attendees are well-versed in delivering top-tier, evidence-based care that aligns with emerging clinical standards.
This event offers an opportunity for healthcare professionals involved in oncology to engage in immersive educational programs. It is dedicated to equipping participants with the knowledge, tools, and strategies necessary to improve patient outcomes through high-quality, integrated cancer care.
From addressing logistical challenges in oncology dispensing to managing complex medication regimens, the event offers practical insights into optimising operations and enhancing the overall patient experience. Case studies, peer discussions, and workshops promote real-world learning and problem-solving.
The 2024 NCODA Oncology Institute is a vital event for oncology professionals committed to advancing their expertise, staying informed about the latest trends, and driving meaningful improvements in cancer care.
The 6th Annual NCODA Oncology Institute took place on August 20-21 in Boston, Massachusetts.
Here are some highlights from 2024 NCODA Oncology Institute:
“This evening, NCODA, together with oncology leaders and industry partners, kicked off the 2024 Oncology Institute in Boston. The Welcome Reception was energized with passionate professionals connecting and sharing ideas to elevate equitable oncology patient care. We look forward to a packed day tomorrow of insightful sessions and meaningful conversations. Thank you to all who have joined us!”
“Excited to be attending and working at the 2024 NCODA Oncology Institute! This event is a fantastic opportunity to connect with other professionals dedicated to improving oncology care. I’m looking forward to engaging with industry leaders, learning, and contributing to discussions that will shape the future of patient-centered care. If you’re attending, let’s connect!”
“Yesterday, I had the incredible opportunity to discuss our commitment to advancing health equity globally, Oncology Health Equity framework and strategies for integrating social determinants of health (SDoH) data into our work at the 6th Annual NCODA Oncology Institute Summit.
Leveraging SDoH data and insights allows us to develop thoughtful and focused programs that make a real difference for impacting patient outcomes and supporting Equitable Care.
Takeaway: We can ALL commit to taking small steps to moving the needle.
Thank you to Sharita Howe for your incredible moderation, and to Luis E Raez and Randi F. for your insights on how we can better foster multi-disciplinary conversations around innovative Health Equity solutions in oncology.
I am also extending my gratitude to my collaborative partners in Managed Markets, Ronald Troast and Bobby Rodgers for their continued support!”
“Discussing social determinants of health (SDOH) and cancer disparities during the 2024 NCODA Oncology Institute!”
“It was an amazing experience to hear about the industry’s efforts to make care delivery and clinical trials more inclusive. Happy to contribute the ways ZS is helping understand the degrees of inequities that exist in healthcare today and the means to effect change.”
“I want to thank NCODA for bringing healthcare providers, life science partners, and a diverse group of advocacy stakeholders together to address this crucial topic. I look forward to discussing how we can collaborate on advancing health equity during this afternoon’s DEEP DIVE 4: Patient Services and Support panel.”
For more updates, visit oncodaily.com